Cardiovascular comorbidities in psoriasis

被引：0

作者：

Loo, S. K. F. ^{[1
]}

Yeung, K. H. ^{[1
]}

Ho, K. M. ^{[1
]}

Lo, K. K. ^{[1
]}

机构：

[1] Dept Hlth, Social Hyg Serv, Hong Kong, Hong Kong, Peoples R China

来源：

HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY | 2010年 / 18卷 / 02期

关键词：

Cardiovascular comorbidities; cardiovascular disease; inflammation; psoriasis; review; ENDOTHELIAL GROWTH-FACTOR; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; VASCULAR-DISEASES; DIABETES-MELLITUS; CORONARY-ARTERY; RISK-FACTORS; PREVALENCE; ASSOCIATION; INFLAMMATION;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Psoriasis is recognized as a chronic, systemic, immune-mediated inflammatory skin disease. Population-based epidemiological studies have shown that patients with moderate to severe psoriasis have an increased risk for various cardiovascular comorbidities including hypertension, diabetes, hyperlipidaemia, obesity, metabolic syndrome and cardiovascular diseases. Associated cardiometabolic risk factors, lifestyle issues, pro-atherogenic medications, and the underlying chronic systemic inflammation of psoriasis may all contribute to the increased cardiovascular risk. While psoriasis may possibly confer an independent risk for myocardial infarction, the evidence is still weak at this moment. Physicians should take a proactive role in the screening and management of the associated cardiometabolic risk factors in patients with psoriasis.

引用

页码：72 / 81

页数：10

共 50 条

[31] Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events [J].

Mehta, Nehal N. ;

Yu, YiDing ;

Pinnelas, Rebecca ;

Krishnamoorthy, Parasuram ;

Shin, Daniel B. ;

Troxel, Andrea B. ;

Gelfand, Joel M. .

AMERICAN JOURNAL OF MEDICINE, 2011, 124 (08) :775.e1-775.e6

[32] Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis [J].

Gualtierotti, Roberta ;

Ughi, Nicola ;

Marfia, Giovanni ;

Ingegnoli, Francesca .

RHEUMATOLOGY AND THERAPY, 2017, 4 (02) :293-308

[33] Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis [J].

Puig, Lluis .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)

[34] Psoriasis and metabolic and cardiovascular comorbidities in children: A systematic review [J].

Badaoui, A. ;

Tounian, P. ;

Mahe, E. .

ARCHIVES DE PEDIATRIE, 2019, 26 (02) :86-94

[35] The Association Between Psoriasis and Cardiovascular Diseases [J].

Zwain, Ahmed ;

Aldiwani, Mohanad ;

Taqi, Hussein .

EUROPEAN CARDIOLOGY REVIEW, 2021, 16

[36] Psoriasis: is it a risk factor for cardiovascular diseases? [J].

Nada, Hesham ;

Elakhrass, Attef ;

Ahmad, Neven ;

Refaat, Mohamed .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (08) :3154-3159

[37] Psoriasis and Cardiovascular Risk: A Comprehensive Review [J].

Masson, Walter ;

Lobo, Martin ;

Molinero, Graciela .

ADVANCES IN THERAPY, 2020, 37 (05) :2017-2033

[38] Psoriasis: comorbidities and associations [J].

Farley, E. ;

Menter, A. .

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2011, 146 (01) :9-15

[39] Cardiovascular comorbidities in rheumatoid arthritis [J].

Krueger, K. ;

Nuesslein, H. .

ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (03) :221-227

[40] Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists [J].

Parsi, Kory K. ;

Brezinski, Elizabeth A. ;

Lin, Tzu-Chun ;

Li, Chin-Shang ;

Armstrong, April W. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (03) :357-362

← 1 2 3 4 5 →